Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Buys Proteomics Sample Prep Company Instrinsic Bioprobes

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today announced it has purchased proteomics sample preparation firm Intrinsic Bioprobes for an undisclosed amount.

Based in Tempe, Ariz., Intrinsic manufactures immuno-enrichment sample prep tools for quantitative mass spectrometry. Among its offerings is the Mass Spectrometric Immunoassay, or MSIA, which allows for the enrichment of low-abundance proteins in biological samples.

The deal, Thermo Fisher said, allows it to offer customers "an enhanced solution for quantitative protein biomarker detection." Coupled with mass spectrometry, MSIA gives researchers a "complete higher-resolution view of the proteome," the company said, adding that Intrinsic's sample prep technologies with Thermo Fisher's automated sample processing, quantitative mass specs, and software "creates a complete, integrated workflow for the quantitative detection of protein biomarkers."

Chuck Kummeth, president of Thermo Fisher's laboratory consumables business, said in a statement that the purchase enhances his firm's position in the "rapidly emerging field of clinical proteomics" and better positions it to help customers "realize the promise of personalized medicine."

Thermo Fisher and Intrinsic have a relationship dating back at least one year when they announced a deal to co-develop and market a mass spec-based solution for quantitative, high-throughput, and high-resolution protein biomarker assays.

The deal also follows Thermo Fisher's recent $3.5 billion purchase of specialty diagnostics firm Phadia.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.